Phentermine is not a semaglutide. They are completely different medications with different chemical structures, different mechanisms, and different drug classifications. The confusion is understandable because both are prescribed for weight loss, but they work in fundamentally different ways inside your body.
How Phentermine Works
Phentermine belongs to a drug class called sympathomimetic amines, which means it stimulates your central nervous system in a way that’s pharmacologically similar to amphetamine. It’s classified as an “anorectic” or appetite suppressant, though its FDA label notes that the exact mechanism isn’t fully understood. Beyond simple appetite suppression, it may also influence metabolism and other brain activity. You take it as a daily oral tablet or capsule, sold under brand names like Adipex-P, Lomaira, and Suprenza.
Phentermine is FDA-approved only for short-term use, typically a few weeks at a time. Because of its stimulant properties, it carries a risk of dependence and is classified as a Schedule IV controlled substance. Its side effect profile leans cardiovascular: increased heart rate, elevated blood pressure, and restlessness are common concerns. It’s also available in a combination pill with topiramate, sold as Qsymia.
How Semaglutide Works
Semaglutide is a GLP-1 receptor agonist, a class of drugs that mimic a natural gut hormone called glucagon-like peptide-1. This hormone does several things at once: it triggers insulin release when blood sugar is high, slows down how quickly food leaves your stomach, and sends fullness signals to appetite centers in the brain. Specifically, semaglutide activates receptors in the hypothalamus that increase “I’m full” chemical signals while dialing down “I’m hungry” ones.
Semaglutide was originally developed for type 2 diabetes (sold as Ozempic and Rybelsus) and later approved at a higher dose for chronic weight management under the brand name Wegovy. The FDA has approved it for long-term use in adults with obesity, or in those who are overweight with at least one weight-related condition. A higher-dose version, Wegovy HD (7.2 mg), was approved for weight loss and long-term maintenance of weight loss. Unlike phentermine, semaglutide is not a controlled substance and is not a stimulant. It’s typically given as a once-weekly injection, though an oral tablet form (Rybelsus) exists for diabetes management.
The most common side effects of semaglutide are gastrointestinal: nausea, vomiting, diarrhea, and constipation, particularly during the initial dose-escalation period. These tend to ease over time as the body adjusts.
Key Differences at a Glance
- Drug class: Phentermine is a stimulant-type appetite suppressant. Semaglutide is a GLP-1 receptor agonist that mimics a gut hormone.
- Duration of use: Phentermine is approved for short-term use only. Semaglutide is approved for long-term, ongoing treatment.
- How you take it: Phentermine is a daily pill. Semaglutide is typically a once-weekly injection (or a daily pill for the diabetes formulation).
- Controlled substance status: Phentermine is a Schedule IV controlled substance. Semaglutide is not a controlled substance.
- Side effect profile: Phentermine’s risks center on cardiovascular stimulation (elevated heart rate and blood pressure). Semaglutide’s most common issues are digestive symptoms like nausea.
Can They Be Used Together?
Because phentermine and semaglutide work through entirely separate pathways, some providers do prescribe them together off-label. The idea is that combining a stimulant-based suppressant with a hormone-based one could produce greater appetite reduction than either drug alone. However, there are no large-scale clinical trials establishing the safety or efficacy of this specific combination, and it’s not an FDA-approved pairing. If you’re currently taking one and considering adding the other, that’s a conversation to have with whoever is managing your prescription.